New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Researchers discover how bowel cancer 'blinds' the immune system

Researchers discover how bowel cancer 'blinds' the immune system

by University of GlasgowCredit: AI-generated imageA mystery which has stumped bowel cancer researchers for decades, has been solved by scientists at the Cancer Research UK Beatson Institute and U
Oncology February 01,2024
Researchers discover how bowel cancer 'blinds' the immune system

Researchers discover how bowel cancer 'blinds' the immune system

by University of GlasgowCredit: AI-generated imageA mystery which has stumped bowel cancer researchers for decades, has been solved by scientists at the Cancer Research UK Beatson Institute and U
Oncology February 01,2024
Vaccination with senescent cells reduces tumor formation in mice

Vaccination with senescent cells reduces tumor formation in mice

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainCells that have permanently stopped multiplying, so-called senescent cells, could play an important role in the fight against cancer, acco
Oncology February 01,2024
Vaccination with senescent cells reduces tumor formation in mice

Vaccination with senescent cells reduces tumor formation in mice

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainCells that have permanently stopped multiplying, so-called senescent cells, could play an important role in the fight against cancer, acco
Oncology February 01,2024
Researchers develop novel gold-nanocluster-based tumor radiodynamic therapy

Researchers develop novel gold-nanocluster-based tumor radiodynamic therapy

by Zhang Nannan,Chinese Academy of SciencesGold-nanocluster-based radiodynamic therapy. Credit: IGDBRadiotherapy (RT) is a primary method of tumor treatment. However, in clinical practice, radio
Oncology February 01,2024
Researchers develop novel gold-nanocluster-based tumor radiodynamic therapy

Researchers develop novel gold-nanocluster-based tumor radiodynamic therapy

by Zhang Nannan,Chinese Academy of SciencesGold-nanocluster-based radiodynamic therapy. Credit: IGDBRadiotherapy (RT) is a primary method of tumor treatment. However, in clinical practice, radio
Oncology February 01,2024
New study shows substantial racial and ethnic disparities among survivors of second primary cancers in the US

New study shows substantial racial and ethnic disparities among survivors of second primary cancers in the US

by American Cancer SocietyResearchers highlight the need for more research to address survival disparities among multiple primary cancer survivors. Credit: American Cancer SocietyIn new findings
Oncology February 01,2024
New study shows substantial racial and ethnic disparities among survivors of second primary cancers in the US

New study shows substantial racial and ethnic disparities among survivors of second primary cancers in the US

by American Cancer SocietyResearchers highlight the need for more research to address survival disparities among multiple primary cancer survivors. Credit: American Cancer SocietyIn new findings
Oncology February 01,2024
Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study

Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study

by Institute for Basic ScienceThe daily fluctuation of proliferative activity of bone marrow is larger in females than in males, and it becomes higher in the morning (left). Thus, chemotherapy in
Oncology February 01,2024
Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study

Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study

by Institute for Basic ScienceThe daily fluctuation of proliferative activity of bone marrow is larger in females than in males, and it becomes higher in the morning (left). Thus, chemotherapy in
Oncology February 01,2024
Drinking alcohol not likely to increase risk of a breast cancer recurrence

Drinking alcohol not likely to increase risk of a breast cancer recurrence

by Kaiser PermanenteCredit: CC0 Public DomainA Kaiser Permanente study provides new information that may help oncologists answer one of the most common questions they hear from breast cancer surv
Oncology February 01,2024
Drinking alcohol not likely to increase risk of a breast cancer recurrence

Drinking alcohol not likely to increase risk of a breast cancer recurrence

by Kaiser PermanenteCredit: CC0 Public DomainA Kaiser Permanente study provides new information that may help oncologists answer one of the most common questions they hear from breast cancer surv
Oncology February 01,2024
Study finds older cancer patients would benefit from geriatric assessment screening

Study finds older cancer patients would benefit from geriatric assessment screening

by Rebecca Biason,University of TorontoEORTC QLQ C30 global health subscale QOL over time. Model predicted QOL stratified by curative versus palliative on the basis of our latent growth curve mo
Oncology February 01,2024
Study finds older cancer patients would benefit from geriatric assessment screening

Study finds older cancer patients would benefit from geriatric assessment screening

by Rebecca Biason,University of TorontoEORTC QLQ C30 global health subscale QOL over time. Model predicted QOL stratified by curative versus palliative on the basis of our latent growth curve mo
Oncology February 01,2024
Researchers use AI to personalize cancer patient treatments

Researchers use AI to personalize cancer patient treatments

by University of SussexCredit: CC0 Public DomainResearchers at the University of Sussex are using Artificial Intelligence (AI) technology to analyze different types of cancer cells to understand
Oncology February 01,2024
Researchers use AI to personalize cancer patient treatments

Researchers use AI to personalize cancer patient treatments

by University of SussexCredit: CC0 Public DomainResearchers at the University of Sussex are using Artificial Intelligence (AI) technology to analyze different types of cancer cells to understand
Oncology February 01,2024
Substance in the blood is found to increase as early as two years before diagnosis of pancreatic cancer

Substance in the blood is found to increase as early as two years before diagnosis of pancreatic cancer

by Ola Nilsson,Umea UniversitySeparating future PDAC cases from controls in pre-diagnostic and diagnostic samples with a cross-sectional analysis. Box plots of the individual marker concentratio
Oncology February 01,2024
Substance in the blood is found to increase as early as two years before diagnosis of pancreatic cancer

Substance in the blood is found to increase as early as two years before diagnosis of pancreatic cancer

by Ola Nilsson,Umea UniversitySeparating future PDAC cases from controls in pre-diagnostic and diagnostic samples with a cross-sectional analysis. Box plots of the individual marker concentratio
Oncology February 01,2024
Study uncovers potential therapeutic approach for advanced prostate cancer

Study uncovers potential therapeutic approach for advanced prostate cancer

by Melissa Rohman,Northwestern UniversityPALI1 bridges the interaction between PRC2 (SUZ12/EZH2/EED) and G9A to catalyze dual H3K9 and H3K27 methylation, which leads to strong repression of GPS
Oncology February 01,2024
Study uncovers potential therapeutic approach for advanced prostate cancer

Study uncovers potential therapeutic approach for advanced prostate cancer

by Melissa Rohman,Northwestern UniversityPALI1 bridges the interaction between PRC2 (SUZ12/EZH2/EED) and G9A to catalyze dual H3K9 and H3K27 methylation, which leads to strong repression of GPS
Oncology February 01,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com